Assessing balance control in older adults with diabetic peripheral neuropathy
Official title: Balance Control and Recovery in Diabetes Peripheral Neuropathy
Run by University of Texas at Austin · NCT06544876 · Data updated 2026-11-12
This study tests how diabetic peripheral neuropathy affects balance and muscle activity in adults over 50 to see if it increases their risk of falling.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 99 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Texas at Austin Academic / other |
| Locations | 1 site (Austin, Texas) |
| Status | Recruiting |
| Started | September 12, 2023 |
| Main results expected | August 31, 2026 |
| Study ends | August 31, 2028 |
| Registry record updated | August 9, 2024 |
| Trial ID | NCT06544876 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 50 years old with Type II diabetes and diagnosed peripheral neuropathy.
✕Probably not a fit
Patients with foot ulcers, partial amputations, or those unable to stand or walk independently may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the impact of diabetic peripheral neuropathy (DPN) on balance control and muscle activity in adults over 50 years old. It aims to measure muscle activity during sit-to-stand transitions and assess balance recovery responses to lateral perturbations while standing. Participants will undergo various assessments, including muscle strength evaluations and sensory measures, to understand how DPN affects their balance and stability. The findings could provide insights into fall risks associated with DPN in older adults.
Why it matters
Potential benefit: If successful, this study could lead to improved strategies for preventing falls in older adults with diabetic peripheral neuropathy.
How similar studies have gone: Other studies have shown success in assessing balance and fall risks in older adults with similar conditions, indicating that this approach is supported by existing research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Type II diabetes with peripheral neuropathy Exclusion Criteria: * Foot ulcer * Partial amputation * Have experience of Stroke * Painful neuropathy * Inability to stand or walk independently
Where it's running
-
The University of Texas at Austin
Austin, Texas, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of perturbation-based balance training vs conventional balance training for reactive stepping in adults with diabetic nerve damage
A 40-person study will test whether adding perturbation-based balance training helps adults with diabetic peripheral neuropathy react better to balance threats compared with standard balance training.
-
Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?
This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
-
Miricell supplementation and markers of healthy aging
This trial tests whether taking Miricell once daily for 12 weeks improves cellular health and brain/metabolic indicators in adults aged 40–70 compared with a placebo.
-
Ultrasound-guided nerve hydrodissection for diabetic leg nerves
A single ultrasound-guided nerve hydrodissection procedure is tested to see if it helps people with diabetic lower limb entrapment neuropathy feel less pain and have better nerve function.
-
Shortwave therapy for diabetic peripheral neuropathy
A one-center study will test whether shortwave therapy given for five days can improve nerve symptoms in adults with diabetic neuropathy compared to a sham treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.